CACI International (CACI) PT Raised to $468 at Wells Fargo

Wells Fargo analyst Matthew Akers raised the price target on CACI International (NYSE: CACI) to $468.00 (from $410.00) while maintaining a Overweight rating.

The analyst commented, "Our updated estimates are ahead of consensus for FY25, which bakes in just 2% growth off of the high end of CACI's FY24 guidance despite new program wins still ramping and very low 1% recompetes. We reiterate our OW rating."

"We are trimming our FY24 EPS estimate to $20.47 (from $20.55), while our FY25 estimate moves slightly higher. Our $468 PT is based on an 18x multiple on our FY26 EPS estimate, roughly where CACI now trades on consensus FY25."

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• CACI opens 61,000-sq-ft defense electronics facility in Rochester
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'